{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T03:57:25Z","timestamp":1790049445185,"version":"4.0.1"},"reference-count":80,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1016\/j.coi.2004.05.013","type":"journal-article","created":{"date-parts":[[2004,6,17]],"date-time":"2004-06-17T16:34:35Z","timestamp":1087490075000},"page":"443-450","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Immunological memory to viral infection"],"prefix":"10.1016","volume":"16","author":[{"given":"Mark K","family":"Slifka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2004.05.013_BIB1","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/infdis\/166.2.244","article-title":"Vaccination of vaccinia-naive adults with human immunodeficiency virus type 1 gp160 recombinant vaccinia virus in a blinded, controlled, randomized clinical trial. The AIDS Vaccine Clinical Trials Network","volume":"166","author":"Graham","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coi.2004.05.013_BIB2_1","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1001\/jama.289.24.3295","article-title":"Response to smallpox vaccine in persons immunized in the distant past","volume":"289","author":"Frey","year":"2003","journal-title":"Jama"},{"key":"10.1016\/j.coi.2004.05.013_BIB3","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1086\/381101","article-title":"Lack of vaccinia viremia after smallpox vaccination","volume":"38","author":"Cummings","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coi.2004.05.013_BIB4","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.288.15.1901","article-title":"Contact vaccinia\u2013transmission of vaccinia from smallpox vaccination","volume":"288","author":"Neff","year":"2002","journal-title":"Jama"},{"key":"10.1016\/j.coi.2004.05.013_BIB5","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1056\/NEJMra022500","article-title":"How contagious is vaccinia?","volume":"348","author":"Sepkowitz","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2004.05.013_BIB6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2105\/AJPH.43.1.25","article-title":"Outbreak of smallpox in the lower Rio Grande valley of Texas in 1949","volume":"43","author":"Irons","year":"1953","journal-title":"Am J Pub Hlth"},{"key":"10.1016\/j.coi.2004.05.013_BIB7_1","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1056\/NEJMsa023184","article-title":"The public and the smallpox threat","volume":"348","author":"Blendon","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2004.05.013_BIB8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.289.2.179","article-title":"Mortality associated with influenza and respiratory syncytial virus in the United States","volume":"289","author":"Thompson","year":"2003","journal-title":"Jama"},{"key":"10.1016\/j.coi.2004.05.013_BIB9","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/jama.1970.03170160031005","article-title":"Deaths attributable to smallpox vaccination, 1959 to 1966, and 1968","volume":"212","author":"Lane","year":"1970","journal-title":"Jama"},{"key":"10.1016\/j.coi.2004.05.013_BIB10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJM196701192760301","article-title":"Complications of smallpox vaccination. I. National survey in the United States, 1963","volume":"276","author":"Neff","year":"1967","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2004.05.013_BIB11","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJM196911272812201","article-title":"Complications of smallpox vaccination, 1968","volume":"281","author":"Lane","year":"1969","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2004.05.013_BIB12","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1001\/jama.289.24.3283","article-title":"Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel","volume":"289","author":"Halsell","year":"2003","journal-title":"Jama"},{"key":"10.1016\/j.coi.2004.05.013_BIB13_1","unstructured":"Centers for Disease Control and Prevention (CDC): Cardiac deaths after a mass smallpox vaccination campaign\u2013New York City, 1947. MMWR Morb Mortal Wkly Rep 2003, 52:933-936."},{"key":"10.1016\/j.coi.2004.05.013_BIB14","unstructured":"Jenner E: An inquiry into the causes and effects of the variole vaccine, or cow-pox. London; 1798."},{"key":"10.1016\/j.coi.2004.05.013_BIB15","unstructured":"Jenner E: A continuation of facts and observations relative to the variole vaccine, or cow-pox. London, 1800."},{"key":"10.1016\/j.coi.2004.05.013_BIB16","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1086\/340517","article-title":"Primary Induction of Human CD8+ Cytotoxic T Lymphocytes and Interferon- gamma-Producing T Cells after Smallpox Vaccination","volume":"185","author":"Ennis","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coi.2004.05.013_BIB17","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1056\/NEJMoa013431","article-title":"Dose-related effects of smallpox vaccine","volume":"346","author":"Frey","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2004.05.013_BIB18","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/nm916","article-title":"Clonal vaccinia virus grown in cell culture as a new smallpox vaccine","volume":"9","author":"Weltzin","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.coi.2004.05.013_BIB19_1","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1084\/jem.20022222","article-title":"Quantitation of CD8+ T Cell Responses to Newly Identified HLA-A*0201-restricted T Cell Epitopes Conserved Among Vaccinia and Variola (Smallpox) Viruses","volume":"197","author":"Terajima","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2004.05.013_BIB20_1","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.4049\/jimmunol.171.10.4969","article-title":"Cutting Edge: Long-Term B Cell Memory in Humans after Smallpox Vaccination","volume":"171","author":"Crotty","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2004.05.013_BIB21","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1128\/JVI.76.7.3329-3337.2002","article-title":"Recombinant vaccinia virus-induced T-cell immunity: quantitation of the response to the virus vector and the foreign epitope","volume":"76","author":"Harrington","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2004.05.013_BIB22","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1073\/pnas.262668999","article-title":"Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines","volume":"100","author":"Drexler","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coi.2004.05.013_BIB23","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.3201\/eid0911.030349","article-title":"Flow cytometry and T-cell response monitoring after smallpox vaccination","volume":"9","author":"Poccia","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.coi.2004.05.013_BIB24_1","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/nm917","article-title":"Duration of antiviral immunity after smallpox vaccination","volume":"9","author":"Hammarlund","year":"2003","journal-title":"Nature Medicine"},{"key":"10.1016\/j.coi.2004.05.013_BIB25","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1128\/jvi.70.4.2627-2631.1996","article-title":"Human cytotoxic T-cell memory: long-lived responses to vaccinia virus","volume":"70","author":"Demkowicz","year":"1996","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2004.05.013_BIB26","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1099\/0022-1317-74-4-751","article-title":"Class I major histocompatibility complex-restricted cytotoxic T cell responses to vaccinia virus in humans","volume":"74","author":"Erickson","year":"1993","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coi.2004.05.013_BIB27","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0022-1759(02)00025-X","article-title":"Ex vivo detection and enumeration of human antigen-specific CD8+ T lymphocytes using antigen delivery by a recombinant vaccinia expression vector and intracellular cytokine staining","volume":"262","author":"Speller","year":"2002","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.coi.2004.05.013_BIB28","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/90950","article-title":"Differential regulation of antiviral T-cell immunity results in stable CD8+ but declining CD4+ T-cell memory","volume":"7","author":"Homann","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.coi.2004.05.013_BIB29","first-page":"466","article-title":"The antibody response in man following infection with viruses of the pox group. II. Antibody response following vaccination","volume":"56","author":"McCarthy","year":"1958","journal-title":"J. Hyg."},{"key":"10.1016\/j.coi.2004.05.013_BIB30","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1093\/infdis\/161.3.446","article-title":"The persistence of neutralizing antibodies after re-vaccination against smallpox","volume":"161","author":"el-Ad","year":"1990","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coi.2004.05.013_BIB31","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0264-410X(98)00197-2","article-title":"Kinetics of formation of neutralizing antibodies against vaccinia virus following re-vaccination","volume":"17","author":"Stienlauf","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2004.05.013_BIB32","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/336070a0","article-title":"B-cell memory is short-lived in the absence of antigen","volume":"336","author":"Gray","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.coi.2004.05.013_BIB33","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1126\/science.1076071","article-title":"Maintenance of serological memory by polyclonal activation of human memory B cells","volume":"298","author":"Bernasconi","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.coi.2004.05.013_BIB34","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/0966-842X(96)10059-7","article-title":"Long-term humoral immunity against viruses: revisiting the issue of plasma cell longevity","volume":"4","author":"Slifka","year":"1996","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.coi.2004.05.013_BIB35","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/40540","article-title":"Lifetime of plasma cells in the bone marrow","volume":"388","author":"Manz","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.coi.2004.05.013_BIB36","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S1074-7613(00)80541-5","article-title":"Humoral immunity due to long-lived plasma cells","volume":"8","author":"Slifka","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2004.05.013_BIB37","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0952-7915(02)00356-4","article-title":"Humoral immunity and long-lived plasma cells","volume":"14","author":"Manz","year":"2002","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.coi.2004.05.013_BIB38","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1126\/science.283.5406.1279","article-title":"The looming threat of bioterrorism","volume":"283","author":"Henderson","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.coi.2004.05.013_BIB39","doi-asserted-by":"crossref","first-page":"959","DOI":"10.3201\/eid0706.010607","article-title":"Modeling potential responses to smallpox as a bioterrorist weapon","volume":"7","author":"Meltzer","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.coi.2004.05.013_BIB40","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/414748a","article-title":"Transmission potential of smallpox in contemporary populations","volume":"414","author":"Gani","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.coi.2004.05.013_BIB41","doi-asserted-by":"crossref","first-page":"10935","DOI":"10.1073\/pnas.162282799","article-title":"Emergency response to a smallpox attack: the case for mass vaccination","volume":"99","author":"Kaplan","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coi.2004.05.013_BIB42","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1086\/339909","article-title":"Shining light on \u201cDark Winter\u201d","volume":"34","author":"O\u2019Toole","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coi.2004.05.013_BIB43","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nri845","article-title":"Smallpox: anything to declare?","volume":"2","author":"Smith","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.coi.2004.05.013_BIB44","first-page":"44","article-title":"Durability of vaccinia immunization based on reaction at the rechallenge site","volume":"3","author":"Sauri","year":"2002","journal-title":"Md Med"},{"key":"10.1016\/j.coi.2004.05.013_BIB45","first-page":"123","article-title":"Studies with dried and glycerinated smallpox vaccines of full and diminished potencies","volume":"19","author":"Cross","year":"1958","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.coi.2004.05.013_BIB46","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0140-6736(65)91146-3","article-title":"Immunogenicity of Ultraviolet-Irradiated, Non-Infectious, Vaccinia-Virus Vaccine in Infants and Young Children","volume":"191","author":"Kaplan","year":"1965","journal-title":"Lancet"},{"key":"10.1016\/j.coi.2004.05.013_BIB47","doi-asserted-by":"crossref","unstructured":"Hanna W: Studies in smallpox and vaccination. New York: William Wood and Company; 1913.","DOI":"10.1097\/00000441-191310000-00015"},{"key":"10.1016\/j.coi.2004.05.013_BIB48","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/rmv.361","article-title":"Studies in smallpox and vaccination. 1913","volume":"12","author":"Hanna","year":"2002","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.coi.2004.05.013_BIB49","doi-asserted-by":"crossref","unstructured":"CDC: Smallpox - Stockholm, Sweden, 1963. MMWR 1963, 12:172, 174-176, 183, 188, 191, 220, 236.","DOI":"10.1001\/jama.1963.03700120145134"},{"key":"10.1016\/j.coi.2004.05.013_BIB50","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/infdis\/125.2.161","article-title":"Smallpox in Europe, 1950-1971","volume":"125","author":"Mack","year":"1972","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coi.2004.05.013_BIB51","unstructured":"Fenner F, Henderson DA, Arita I, Jezek Z, Ladnyi ID: Smallpox and its eradication. In The pathogenesis, immunology, and pathology of smallpox and vaccinia. Geneva: World Health Organization; 1988."},{"key":"10.1016\/j.coi.2004.05.013_BIB52","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/aje\/kwg225","article-title":"Analysis of historical data suggests long-lasting protective effects of smallpox vaccination","volume":"158","author":"Eichner","year":"2003","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.coi.2004.05.013_BIB53_1","doi-asserted-by":"crossref","unstructured":"Whitton JL, Slifka MK, Liu F, Nussbaum AK, Whitmire JK: The regulation and maturation of antiviral immune responses. Adv Vir Res 2004, in press.","DOI":"10.1016\/S0065-3527(04)63003-X"},{"key":"10.1016\/j.coi.2004.05.013_BIB54","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1056\/NEJM198703123161106","article-title":"Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease","volume":"316","author":"Redfield","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2004.05.013_BIB55","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1086\/375823","article-title":"Separate worlds set to collide: smallpox, vaccinia virus vaccination, and human immunodeficiency virus and acquired immunodeficiency syndrome","volume":"37","author":"Amorosa","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coi.2004.05.013_BIB56","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1086\/368093","article-title":"Smallpox vaccination and patients with human immunodeficiency virus infection or acquired immunodeficiency syndrome","volume":"36","author":"Bartlett","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coi.2004.05.013_BIB57","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/0140-6736(91)91269-Z","article-title":"Anti-HIV cellular immunotherapy in AIDS","volume":"338","author":"Zagury","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.coi.2004.05.013_BIB58","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1542\/peds.26.2.176","article-title":"Studies on smallpox and complications of smallpox vaccination","volume":"25","author":"Kempe","year":"1960","journal-title":"Pediatrics"},{"key":"10.1016\/j.coi.2004.05.013_BIB59_1","doi-asserted-by":"crossref","first-page":"9458","DOI":"10.1073\/pnas.1233578100","article-title":"Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses","volume":"100","author":"Belyakov","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coi.2004.05.013_BIB60","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1128\/jvi.66.4.2274-2280.1992","article-title":"Vaccinia virus-specific human CD4+ cytotoxic T-lymphocyte clones","volume":"66","author":"Littaua","year":"1992","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2004.05.013_BIB61","doi-asserted-by":"crossref","first-page":"988","DOI":"10.4049\/jimmunol.139.4.988","article-title":"Proliferative and cytotoxic T cells to AIDS virus glycoproteins in chimpanzees immunized with a recombinant vaccinia virus expressing AIDS virus envelope glycoproteins","volume":"139","author":"Zarling","year":"1987","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2004.05.013_BIB62","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1165\/ajrcmb\/3.5.431","article-title":"Human ciliated bronchial epithelial cells: expression of the HLA-DR antigens and of the HLA-DR alpha gene, modulation of the HLA-DR antigens by gamma-interferon and antigen-presenting function in the mixed leukocyte reaction","volume":"3","author":"Rossi","year":"1990","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.coi.2004.05.013_BIB63","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1365-2222.1997.tb00709.x","article-title":"HLA class II antigens and T lymphocytes in human nasal epithelial cells. Modulation of the HLA class II gene transcripts by gamma interferon","volume":"27","author":"Wang","year":"1997","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.coi.2004.05.013_BIB64","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0192-0561(00)00020-5","article-title":"Effects of interferons alpha and gamma on cytokine production and phenotypic pattern of human bronchial epithelial cells","volume":"22","author":"Striz","year":"2000","journal-title":"Int J Immunopharmacol"},{"key":"10.1016\/j.coi.2004.05.013_BIB65","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1097\/00005537-200211000-00030","article-title":"HLA-DR and ICAM-1 expression and modulation in epithelial cells from nasal polyps","volume":"112","author":"Papon","year":"2002","journal-title":"Laryngoscope"},{"key":"10.1016\/j.coi.2004.05.013_BIB66","doi-asserted-by":"crossref","first-page":"9287","DOI":"10.1128\/JVI.77.17.9287-9294.2003","article-title":"Human cytomegalovirus US2 causes similar effects on both major histocompatibility complex class I and II proteins in epithelial and glial cells","volume":"77","author":"Hegde","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2004.05.013_BIB67","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1365-2249.2003.02301.x","article-title":"Differential major histocompatibility complex class II locus expression on human laryngeal epithelium","volume":"134","author":"Rees","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.coi.2004.05.013_BIB68","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1086\/378518","article-title":"Modeling a safer smallpox vaccination regimen, for human immunodeficiency virus type 1-infected patients, in immunocompromised macaques","volume":"188","author":"Edghill-Smith","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coi.2004.05.013_BIB69","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4269\/ajtmh.1972.21.214","article-title":"A prospective study of serum antibody and protection against smallpox","volume":"21","author":"Mack","year":"1972","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.coi.2004.05.013_BIB70","first-page":"307","article-title":"The minimum protective level of antibodies in smallpox","volume":"52","author":"Sarkar","year":"1975","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.coi.2004.05.013_BIB71","first-page":"479","article-title":"The antibody response in man following infection with viruses of the pox group. III. Antibody response in smallpox","volume":"56","author":"Downie","year":"1958","journal-title":"J. Hyg."},{"issue":"Pt 10","key":"10.1016\/j.coi.2004.05.013_BIB72","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1099\/0022-1317-71-10-2341","article-title":"Structural and functional analysis of orthopoxvirus epitopes with neutralizing monoclonal antibodies","volume":"71","author":"Czerny","year":"1990","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coi.2004.05.013_BIB73","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1006\/viro.1998.9516","article-title":"Neutralizing and protective antibodies directed against vaccinia virus envelope antigens","volume":"254","author":"Galmiche","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.coi.2004.05.013_BIB74","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1099\/0022-1317-83-5-1059","article-title":"Administration to mice of a monoclonal antibody that neutralizes the intracellular mature virus form of vaccinia virus limits virus replication efficiently under prophylactic and therapeutic conditions","volume":"83","author":"Ramirez","year":"2002","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coi.2004.05.013_BIB75","first-page":"59","article-title":"Immunotherapie de la Variole","volume":"1","author":"Couzi","year":"1941","journal-title":"Bulletin de l\u2019Institut d\u2019hygiene du Maroc"},{"key":"10.1016\/j.coi.2004.05.013_BIB76","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1542\/peds.18.2.177","article-title":"Hyperimmune vaccinial gamma globulin","volume":"18","author":"Kempe","year":"1956","journal-title":"Pediatrics"},{"key":"10.1016\/j.coi.2004.05.013_BIB77","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(58)90351-9","article-title":"Antivaccinial gamma-globulin in smallpox prophylaxis","volume":"2","author":"Peirce","year":"1958","journal-title":"Lancet"},{"key":"10.1016\/j.coi.2004.05.013_BIB78","first-page":"41","article-title":"The use of vaccinia hyperimmune gammaglobulin in the prophylaxis of smallpox","volume":"25","author":"Kempe","year":"1961","journal-title":"Bull WHO"},{"key":"10.1016\/j.coi.2004.05.013_BIB79","first-page":"325","article-title":"The use of hyperimmune antivaccinia gamma-globulin for the prevention and treatment of smallpox","volume":"27","author":"Marennikova","year":"1962","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.coi.2004.05.013_BIB80","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1553-2712.2003.tb00042.x","article-title":"Emergency physicians\u2019 perspectives on smallpox vaccination","volume":"10","author":"Kwon","year":"2003","journal-title":"Acad Emerg Med"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791504000822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791504000822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:15:39Z","timestamp":1760602539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791504000822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":80,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S0952791504000822"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2004.05.013","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunological memory to viral infection","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2004.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}